These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

924 related articles for article (PubMed ID: 28213860)

  • 1. Epidemiology of stone disease across the world.
    Sorokin I; Mamoulakis C; Miyazawa K; Rodgers A; Talati J; Lotan Y
    World J Urol; 2017 Sep; 35(9):1301-1320. PubMed ID: 28213860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and kidney stone disease: a systematic review.
    Carbone A; Al Salhi Y; Tasca A; Palleschi G; Fuschi A; De Nunzio C; Bozzini G; Mazzaferro S; Pastore AL
    Minerva Urol Nefrol; 2018 Aug; 70(4):393-400. PubMed ID: 29856171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary prevention of nephrolithiasis is cost-effective for a national healthcare system.
    Lotan Y; Buendia Jiménez I; Lenoir-Wijnkoop I; Daudon M; Molinier L; Tack I; Nuijten MJ
    BJU Int; 2012 Dec; 110(11 Pt C):E1060-7. PubMed ID: 22686216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and urolithiasis: evidence of regional influences.
    Trinchieri A; Croppi E; Montanari E
    Urolithiasis; 2017 Jun; 45(3):271-278. PubMed ID: 27488444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030.
    Antonelli JA; Maalouf NM; Pearle MS; Lotan Y
    Eur Urol; 2014 Oct; 66(4):724-9. PubMed ID: 25015037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and economics of nephrolithiasis.
    Ziemba JB; Matlaga BR
    Investig Clin Urol; 2017 Sep; 58(5):299-306. PubMed ID: 28868500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of Urolithiasis: Trends in Prevalence, Treatments, and Costs.
    Raheem OA; Khandwala YS; Sur RL; Ghani KR; Denstedt JD
    Eur Urol Focus; 2017 Feb; 3(1):18-26. PubMed ID: 28720363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized Intervention in Monogenic Stone Formers.
    Policastro LJ; Saggi SJ; Goldfarb DS; Weiss JP
    J Urol; 2018 Mar; 199(3):623-632. PubMed ID: 29061541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and medical management of kidney stones in children.
    Tasian GE; Copelovitch L
    J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of urolithiasis: an update.
    Trinchieri A
    Clin Cases Miner Bone Metab; 2008 May; 5(2):101-6. PubMed ID: 22460989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Disorders in Patients with Nephrolithiasis in Iran.
    Shahidi S; Ghasemi G
    Iran J Kidney Dis; 2022 Jan; 1(1):1-5. PubMed ID: 35271494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrolithiasis in Israel: Epidemiological Characteristics of Return Patients in a Tertiary Care Center.
    Abu-Ghanem Y; Kleinmann N; Winkler HZ; Zilberman DE
    Isr Med Assoc J; 2016 Dec; 18(12):725-728. PubMed ID: 28457074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of chronic and end stage kidney disease in patients with nephrolithiasis.
    Shoag J; Halpern J; Goldfarb DS; Eisner BH
    J Urol; 2014 Nov; 192(5):1440-5. PubMed ID: 24929140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economics and cost of care of stone disease.
    Lotan Y
    Adv Chronic Kidney Dis; 2009 Jan; 16(1):5-10. PubMed ID: 19095200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study.
    Lieske JC; de la Vega LS; Gettman MT; Slezak JM; Bergstralh EJ; Melton LJ; Leibson CL
    Am J Kidney Dis; 2006 Dec; 48(6):897-904. PubMed ID: 17162144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A large 15 - year database analysis on the influence of age, gender, race, obesity and income on hospitalization rates due to stone disease.
    Mello MF; Marchini GS; Câmara C; Danilovic A; Levy R; Eluf-Neto J; Srougi M; Mazzucchi E
    Int Braz J Urol; 2016; 42(6):1150-1159. PubMed ID: 27622280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new epidemiology of nephrolithiasis.
    Shoag J; Tasian GE; Goldfarb DS; Eisner BH
    Adv Chronic Kidney Dis; 2015 Jul; 22(4):273-8. PubMed ID: 26088071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on the changing epidemiology and metabolic risk factors in pediatric kidney stone disease.
    Sas DJ
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):2062-8. PubMed ID: 21737846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary advice for patients with bowel-related conditions and malabsorption.
    İbis MA; Oktar A; Gokce MI
    World J Urol; 2023 May; 41(5):1235-1242. PubMed ID: 36648528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.